A Randomized Double-Blind Placebo-Controlled Study to Assess Immunization Responses in Adult and Adolescent Subjects with Moderate-to-Severe Atopic Dermatitis Treated with Nemolizumab
-
- STATUS
- Not Recruiting
-
- participants needed
- 4
Summary
Adult subjects over the age of 18 through age 54 diagnosed with Atopic Dematitis. The research study is being conducted to learn how an investigational drug called nemolizumab affects the immune response to vaccines. Procedures include Physical exam, Medical History, Vital signs, Blood and Urine tests, Electrocardiogram and Subject Questionnaires Key eligibility include Chronic AD for at least 2 years before the screening visit, EASI score greater than 16 and IGA score greater than 3 at both the screening and baseline visits, AD involvement greater than 10% of BSA at both the screening and baseline visits
Details
| Condition | Atopic Dermatitis |
|---|---|
| Age | 99years or below |
| Clinical Study Identifier | TBD |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.